NEW YORK UNIVERSITY SCHOOL OF MEDICINE
CD37 as a Regulator of Platelet Patho(Physiological) Responses
CD37 as a Regulator of Platelet Patho(Physiological) Responses is a funding opportunity from NEW YORK UNIVERSITY SCHOOL OF MEDICINE, up to 579849, closing June 30, 2028.
Jun 30, 2028
(700d left)Overview
SUMMARY Eighty-five percent (85%) of cardiovascular disease deaths occur due to either myocardial infarction (MI) or stroke, platelet-driven events. While antiplatelet therapy for secondary CVD prevention is well-established, antiplatelet therapy is not commonly prescribed to prevent a first MI or stroke as the…